Article R232-11 of the French Sports Code
The College of the French Anti-Doping Agency may, within the limits that it determines, delegate decisions relating to the approval provided for in article R. 232-41-12-3 and the Therapeutic Use Exemption provided for in article L. 232-2 to the President of the Agency. The President may, within the limits that he determines, delegate the signature of these decisions to agents of the Agency. The College may, within the limits it…